Mark Nance joined Mylan as SVP and General Counsel in early 2012. Mylan Inc., which provides products to customers in more than 150 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies. Previously he served as the general counsel of General Electric Company’s only pharmaceutical business, which specializes in diagnostic pharmaceuticals and other high value diagnostic technologies.
Mr. Nance graduated from the University of Missouri and was commissioned an officer in the United States Marine Corps where he served globally in various roles for several years. Mr. Nance then attended Cornell Law School and upon graduation entered private practice with a large law firm specializing in M&A and securities work. He left the law firm to join a series of start-up and emerging technology companies in the IT and biotech fields. During this time, he also served as an advisor to the Chairman of the United States Federal Trade Commission specializing in areas of technology and antitrust policy.
Mr. Nance is a member of the U.S. National Science Advisory Board for Biosecurity where he chaired the Codes of Conduct in the Life Sciences working group and is a board member of the Alliance for the Prudent Use of Antibiotics.
